New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and <i>In Vitro</i> Effect on Glioblastoma-Reference-Cited by-同舟云学术

New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and In Vitro Effect on Glioblastoma

Published:2024-04-05 Issue: Volume: Page:
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Horváth Lilla¹,Biri-Kovács Beáta¹^ORCID,Baranyai Zsuzsa¹^ORCID,Stipsicz Bence¹²,Méhes Előd³,Jezsó Bálint⁴⁵,Krátký Martin⁶,Vinšová Jarmila⁶,Bősze Szilvia¹^ORCID

Affiliation:

1. ELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Eötvös Loránd University, Budapest 1117, Hungary

2. Institute of Biology, Doctoral School of Biology, Eötvös Loránd University, Budapest 1117, Hungary

3. Institute of Physics, Department of Biological Physics, Eötvös Loránd University, Budapest 1117, Hungary

4. Research Centre for Natural Sciences, Institute of Enzymology, Budapest 1053, Hungary

5. ELTE-MTA “Momentum” Motor Enzymology Research Group, Department of Biochemistry, Eötvös Loránd University, Budapest 1117, Hungary

6. Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 03 Hradec Králové, Czech Republic

Funder

Nemzeti Kutat?si, Fejleszt?si ?s Innovaci?s Alap

European Regional Development Fund

National Research, Development and Innovation Office

EFSA-CDN

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c05727

Reference134 articles.

1. Glioblastoma multiforme: The terminator

2. Glioblastoma multiforme: a review of where we have been and where we are going

3. Glioblastoma multiforme: a review of therapeutic targets

4. Glioblastoma multiforme: Pathogenesis and treatment